IDO1 and breast cancer: Evidence from Pakistan showed that from a total of 100 BC patients, high IDO was observed in TNBC patients compared to non-TNBC patients, at 65.3% and 33.3%, respectively, and this overexpression of IDO was associated with decreased overall patient survival [264].